Patients with chromophobe RCC are more likely to experience complete recovery of kidney function after radical nephrectomy, and this is associated with better survival. While uncommon, complete ...

Stand with science,” Kokilaben Dhirubhai Ambani Hospital has achieved a significant milestone in global healthcare delivery. In a powerful demonstration of science and cross-border collaboration, Dr.

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...

In a radical nephrectomy, a surgeon removes your entire kidney and the surrounding tissue. It’s a common and effective surgery that aims to cure kidney cancer before it spreads. “Radical” is the term ...

A laparoscopic nephrectomy involves the removal of one kidney through a series of small incisions with a special tool called a laparoscope. It’s an option to treat kidney cancer and other conditions ...

In a partial nephrectomy, a portion of your kidney is surgically removed, sparing some function in that kidney. This surgery is most often performed in instances of a small tumor localized to the ...

Show More Hiten D. Patel and Mohamad E. Allaf, Johns Hopkins University School of Medicine, Baltimore, MD; Jose A. Karam, The University of Texas MD Anderson Cancer Center, Houston, TX. Despite the ...

Keytruda after nephrectomy improved disease-free survival rates in patients with clear cell renal cell carcinoma regardless of disease risk or stage. Patients with clear cell renal cell carcinoma (RCC ...

January 10, 2008 — Most patients found to have a small kidney tumor, between 2 and 4 cm in size, have the whole kidney removed. However, new findings suggest that for younger patients a partial ...

Immunotherapy combinations tended to improve outcomes for patients with metastatic kidney cancer who go on to receive surgery. Pre-surgical immunotherapy combinations reduce tumor size and help kill ...

Patients with liver metastases, larger tumors, and elevated preoperative C-reactive protein are at higher risk for early recurrence after cytoreductive nephrectomy and complete metastasectomy.